SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1

CUSIP: 84763AAB4

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Debt / NOTE 2.750%12/1
Market price (% of par)
141.69%
Total 13F principal
$103,974,000
Principal change
+$10,826,000
Total reported market value
$147,230,858
Number of holders
13
Value change
+$16,102,467
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 as of Q3 2017

As of 30 Sep 2017, SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 was held by 13 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $103,974,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, SONORA INVESTMENT MANAGEMENT, LLC, FMR LLC, Context Capital Management, LLC, OAKTREE CAPITAL MANAGEMENT LP, BASSO CAPITAL MANAGEMENT, L.P., and ASHFORD CAPITAL MANAGEMENT INC. This page lists 13 institutional bondholders reporting positions for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.